Restoration of cardiomyocyte function in streptozotocin-induced diabetic rats after treatment with vanadate in a tea decoction

Current Pharmaceutical Biotechnology

Volumn 11, Issue 8, 2010, Pages 906-910

  Clark, Tod A ^a   Maddaford, Thane G ^a   Tappia, Paramjit S ^a   Heyliger, Clayton E ^b   Ganguly, Pallab K ^c   Pierce, Grant N ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b ROSS UNIVERSITY SCHOOL OF VETERINARY MEDICINE   (Saint Kitts and Nevis)

^c ALFAISAL UNIVERSITY   (Saudi Arabia)

Author keywords

Calcium; Cardiomyocyte; Contraction; Diabetes; Phosphatidic acid; Tea; Therapy; Vanadate

Indexed keywords

BLACK TEA EXTRACT; CALCIUM ION; INOSITOL TRISPHOSPHATE; INSULIN; PHOSPHATIDIC ACID; PHOSPHOLIPASE C; VANADIC ACID; CALCIUM;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; HEART CONTRACTION; HEART FUNCTION; HEART MUSCLE CELL; NONHUMAN; PERFUSION; RAT; STREPTOZOCIN DIABETES; ANIMAL; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; METABOLISM; SPRAGUE DAWLEY RAT; TEA;

ANIMALIA; CAMELLIA SINENSIS; RATTUS;

ANIMALS; BLOOD GLUCOSE; CALCIUM; DIABETES MELLITUS, EXPERIMENTAL; MYOCYTES, CARDIAC; PHOSPHATIDIC ACIDS; RATS; RATS, SPRAGUE-DAWLEY; TEA; VANADATES;

EID: 79957977089     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920110793261999     Document Type: Article

References (24)

1. Pierce, G.N.; Beamish, R.E.; Dhalla, N.S. Heart Dysfunction in Diabetes. CRC Press: Boca Raton, 1988, pp. 1-245.
2. Regan, T.J. Congestive heart failure in the diabetic. Annu. Rev. Med. 1983, 34. 161-168.
3. Dhalla, N.S.; Pierce, G.N.; Innes, I.R.; Beamish, R.E. Pathogenesis of cardiac dysfunction in diabetes mellitus. Can. J. Cardiol., 1985, 1. 263-281.
4. 2+binding by and composition of the cardiac sarcolemmal membrane in chronic diabetes. Proc. Natl. Acad. Sci. USA, 1983, 80, 5412-5416.
5. 2+pump activity during diabetes mellitus. Am. J. Physiol., 1987, 252, H540-H544.
6. Ganguly, P.K.; Pierce, G.N.; Dhalla, K.S.; Dhalla, N.S. Defective sarcoplasmic reticular calcium transport in diabetic cardiomyopathy. Am. J. Physiol., 1983, 244, E528-E535.
7. Penpargkul, S; Schaible, T; Yipintsoi, T; Scheuer, J. The effect of diabetes on performance and metabolism of rat hearts. Circ. Res., 1980, 47, 911-921.
8. Fein, F.S.; Kornstein, L.B.; Strobeck, J.E.; Capasso, J.M.; Sonnenblick, E.H. Altered myocardial mechanics in diabetic rats. Circ. Res., 1980, 47, 922-933.
9. Panagia, V.; Ou, C.; Taira, Y.; Dai, J.; Dhalla, N.S. Phospholipase D activity in subcellular membranes of rat ventricular myocardium. Biochem. Biophys. Acta, 1991, 1064. 242-250.
10. Kurz, T.; Wolf, R.A.; Corr, P.B. Phosphatidic acid stimulates inositol 1,4,5-trisphosphate production in adult cardiac myocytes. Circ. Res., 1993, 72. 701-706.
11. 3H]INS(1,4,5)P3 binding site in rat heart sarcoplasmic reticulum. J. Mol. Cell. Cardiol., 1994, 26, 341-349.
12. Gilbert, J.C.; Shirayama, T.; Pappano, A.J. Inositol trisphosphate promotes Na-Ca exchange current by releasing calcium from sarcoplasmic reticulum in cardiac myocytes. Circ. Res., 1991, 69. 1632-1639.
13. 2+to phosphatidic acid in chronic diabetes. Can. J. Physiol., 1996, 12, 1092-1098.
14. Tappia, P.S.; Maddaford, T.G.; Hurtado, C.; Dibrov, E.; Austria, J.A.; Sahi, N.; Panagia, V.; Pierce, G.N. Defective phosphatidic acid-phospholipase C signaling in diabetic cardiomyopathy. Biochem. Biophys. Res. Commun., 2004, 316. 280-289.
15. Clark, T.A.; Heyliger, C.E.; Goel, D.P.; Pierce, G.N. The use of tea as a non-toxic modality to deliver vanadate to streptozotocininduced diabetic rats. Metabolism. 2004, 53. 1145-1151.
16. Maddaford, T.G.; Hurtado, C.; Austria, J.A.; Pierce, G.N. A model of low-flow ischemia and reperfusion in single, beating adult cardiomyocytes. Am. J. Physiol., 1999, 277. H788-H798.
17. 2+handling in ventricular myocytes isolated from diabetic rats. Am. J. Physiol., 1996, 270. H1529-H1537.
18. 2+in the heart during diabetes. Cardiovasc. Res. 1997, 34. 41-47.
19. Pierce, G.N.; Dhalla, N.S. Mechanisms of the defect in cardiac myofibrillar function during diabetes. Am. J. Physiol., 1985, 248. E170-E175.
20. Clark, T.A.; Edel, A.L.; Heyliger, C.E.; Pierce, G.N. Effective control of glycemic status and toxicity in Zucker Diabetic Fatty rats with an orally administered vanadate compound. Can. J. Physiol. Pharmacol., 2004, 82, 888-894.
21. Srivastava, A.K. Anti-diabetic and toxic effects of vanadium compounds. Mol. Cell. Biochem., 2000, 206. 177-182.
22. Domingo, J.L. Vanadium and diabetes. What about vanadium toxicity? Mol. Cell. Biochem., 2000, 203,185-187.
23. Cam, M.C.; Brownsey, R.W.; McNeill, J.H. Mechanisms of vanadium action: Insulin-mimetic or insulin-enhancing agent? Can. J. Physiol. Pharmacol. 2000, 78, 829-847.
24. Pandey, S.K.; Anand-Srivastava, M.B.; Srivastava, A.K. Vanadyl sulphate-stimulated glycogen synthesis is associated with activation of phosphatidylinositol 3-kinase and is independent on insulin receptor tyrosine phosphorylation. Biochemistry, 1998, 37. 7006-7014.